Evidence map›Paper›PMID 26742797›Full record

ReviewStroke2016

Modeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives.

Paul M Holloway, Felicity N E Gavins

Abstract readReview
In one paragraph

Review in Stroke, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Advances in three-dimensional modeling of ischemic injury.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. New approach to control ischemic severity ex vivo.Journal of neuroscience methods · 2025
    Article
  15. Article
  16. Advanced rehabilitation in ischaemic stroke research.Stroke and vascular neurology · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paul M HollowayFrom the Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA.
Felicity N E GavinsFrom the Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA. fgavin@lsuhsc.edu.

Funding

Cerebral Microvascular Dysfunction in Sickle Cell DiseaseR56HL125572 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI GAVINS, FELICITY NICOLA EMMA · 2015 to 2015
$363k
Medical Research Council MC_PC_12015NHLBI NIH HHS HL125572-01A1NHLBI NIH HHS R56 HL125572
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain IschemiaModels, NeurologicalStrokeAnimalsBiomedical ResearchBlood-Brain BarrierCell Culture TechniquesCell LineCell Line, TumorDisease Models, AnimalHumansIn Vitro TechniquesOrgan Culture TechniquesStem Cellsblood-brain barrierendothelial cellsin vitro techniquesstroketissue-type plasminogen activator

Identifiers

PMID26742797
PMCPMC4729600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.